21 May 2013
Keywords: analysts, rate, firm, znomics, speculative, buy, price
Article | 22 September 2008
Independent firm Beacon Equity Research's analyst Victor Sula has issued a report that rates US biotechnology company Znomics as a " ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 September 2008
20 May 2013
© 2013 thepharmaletter.com